Wroclaw

The trials here

What the 13 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia4 trials
• Childhood cancers3 trials
• High blood pressure3 trials
• Familial hypercholesterolaemia2 trials
• Multiple sclerosis2 trials
• Pulmonary arterial hypertension2 trials
• Acute myeloid leukaemia1 trial
• Alzheimer disease1 trial
• Coronary artery disease1 trial
• Heart failure1 trial
• Myeloproliferative neoplasms1 trial
• Stroke1 trial
• and 1 more

Phase

• Phase 26 trials
• Phase 35 trials
• Phase 1/21 trial
• Phase 41 trial

Status

• Active, not recruiting7 trials
• Completed3 trials
• Terminated2 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals13 trials

Running trials

• Recruiting

  Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

  NCT07354074· Phase 2· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Early Alzheimer's Disease

  NCT07094516· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia

  NCT04925479· Phase 1/2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS

  NCT03650114· Phase 3· Novartis Pharmaceuticals· Source

• Active, not recruiting

  CINC424A2X01B Rollover Protocol

  NCT02386800· Phase 4· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis

  NCT01892722· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Chronic myeloid leukaemia1 recruiting

Closed trials

• Terminated

  Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants

  NCT05764265· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

  NCT05562934· Phase 2· Novartis Pharmaceuticals· Source

• Terminated

  Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension

  NCT05135000· Phase 2· Novartis Pharmaceuticals· Source

• Completed

  Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

  NCT03785405· Phase 3· Novartis Pharmaceuticals· Source

• Completed

  Study of Efficacy and Safety of Asciminib in Combination With Imatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Have Been Previously Treated With Imatinib and Have Not Achieved Deep Molecular Response.

  NCT03578367· Phase 2· Novartis Pharmaceuticals· Source